https://www.newswise.com/articles/lji-scientists-uncover-the-structure-and-function-of-inmazeb-the-first-fda-approved-drug-for-ebola-virus-infection
0
0
1/30/23 at 9:30pm
Organization
Newswise
44 words
0
Comments
Inmazeb (REGN-EB3), developed by Regeneron, is a three-antibody cocktail designed to target the Ebola virus glycoprotein. The drug was first approved for clinic
You are the first to view
Create an account
or login to join the discussion